Gelonghui, May 20, 丨 Matilda Biotech (002932.SZ) announced that up to May 20, 2024, the company had repurchased 4,966,031 shares of the company through a dedicated securities account, accounting for 2.14% of the company's total share capital; the highest transaction price for repurchased shares was 20.98 yuan/share, the minimum transaction price was 19.30 yuan/share, and the total transaction amount was RMB 100,042,919.81 (excluding transaction taxes and fees).
明德生物(002932.SZ)：已累计回购2.14%股份
Mingde Biotech (002932.SZ): 2.14% of shares have been repurchased cumulatively
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.